Dynamx medical logo


Dynamx medical imageDynamX Medical is developing a biopsy triaging system that aims to identify healthy and benign tissue specimens with high accuracy within seconds.

DynamX Medical Ltd was set up to commercialise research into the application of infrared spectroscopy to the diagnosis of cancer. The Company is developing a system that aims to enable rapid, accurate point-of-care screening of biopsies for pre-cancer/cancer.

The Company suggests that this will save time and money on more complex analyses and reduce time to diagnosis for both healthy and pre-cancer/cancer patients.

DynamX Medical’s flagship product is the biopsy triaging system, DynamX-Bx. This comprises DynamX software, which carries the unique patent-pending diagnostic algorithm and a user interface, combined with a commercially available infrared spectrometer. The system has a small footprint (approx. the size of a large laptop), can be installed near-patient and can be operated with minimal training.


ProductLife sciences EIS
SectorCancer Diagnostics
Aim of fundingGrowth
HMRC Advanced Assurance receivedYes
Envisaged investor exitIPO or Trade Sale
Targeted returnIn excess of 3-5x invested